Drug Trial Radar · NCT04934072
A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis
Last checked: Nov 19, 2026Latest source record: Feb 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
553
Actual
Start
Jun 16, 2021
Primary completion
Aug 7, 2023
Study completion Aug 7, 2023
Sponsor
- Lead sponsor
- Fresenius Kabi SwissBioSim GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jun 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 55 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to demonstrate equivalent efficacy of the proposed biosimilar denosumab FKS518 to US-licensed Prolia in women with postmenopausal osteoporosis (PMO).
Conditions
- Postmenopausal Osteoporosis
Interventions
FKS518Drug
subcutaneously by single-use prefilled syringe (PFS)
US-licensed Prolia (Amgen)Drug
subcutaneously by single-use PFS
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage Change From Baseline in LS-BMD by DXATime frame: Baseline and Week 52
Locations
76 sites in 6 countries. Site status is shown where the registry gives one.
Medical Center Hipokrat 2000 OOD
Haskovo, Bulgaria
Medical Center Medconsult Pleven
Pleven, Bulgaria
Palmed University Multidisciplinary Hospital for Active Treatment
Plovdiv, Bulgaria
University Multi-profile Hospital for Active Treatment - Plovdiv
Plovdiv, Bulgaria
Medical Center - Teodora EOOD
Rousse, Bulgaria
Multiprofile Hospital for Active Treatment Hadzhi Dimitar
Sliven, Bulgaria
Lyulin Hospital
Sofia, Bulgaria
Diagnostic and Consultative Center Equita
Varna, Bulgaria
Medical Center Sanador M
Vidin, Bulgaria
Diagnostic Consultative Center Aleksandrovska
Sofia, Sofia-Grad, Bulgaria
Diagnostic Consultative Center (DCC) 17 - Sofia
Sofia, Sofia-Grad, Bulgaria
Medical Center N. I. Pirogov
Sofia, Sofia-Grad, Bulgaria
G-Centrum Olomouc s.r.o
Olomouc, Czechia
Artroscan
Ostrava-T?ebovice, Czechia
Medical Plus
Uherské Hradiště, Czechia
CCR Brno
Brno, Jihormoravsky Kraj, Czechia
CCR Ostrava
Ostrava, Severomoravsky Kraj, Czechia
Medical Plus
Uherské Hradiště, South Moravian, Czechia
KLV Arstikabinet
Pärnu, Estonia
Center for Clinical and Basic Research AS - Tallinn
Tallinn, Harju, Estonia
Sihtasutus Pohja-Eesti Regionaalhaigla
Tallinn, Harju, Estonia
KLV Arstikabinet
Pärnu, Pärnumaa, Estonia
Tartu Ulikooli Kliinikum
Tartu, Tartu, Estonia
Hepatology Clinic Hepa
Tbilisi, Georgia
Tbilisi Heart And Vascular Clinic Ltd
Tbilisi, Georgia
Jerarsi Clinic
Tbilisi, Georgia
Raymann - Clinic of Raymann Doctors
Tbilisi, Georgia
MedCity Ltd.
Tbilisi, Georgia
Evex Hospitals - Caraps Medline
Tbilisi, Borjomi, Georgia
Georgian-Dutch Hospital
Tbilisi, Borjomi, Georgia
Drug Research Center Balatonfured
Balatonfüred, Hungary
Revita Rendel?
Budapest, Hungary
Clinexpert Gyogycentrum
Budapest, Hungary
Obudai Egeszsegugyi Centrum
Budapest, Hungary
Semmelweis Egyetem - I. sz. Belgyogyaszati Klinika
Budapest, Hungary
Debreceni Egyetem Klinikai Kozpont Kenezy Gyula Campus
Debrecen, Hungary
Markhot Ferenc Oktatokorhaz es Rendel?intezet
Eger, Hungary
Kalocsai Szent Kereszt Korhaz
Kalocsa, Hungary
CMed Rehabilitacios es Diagnosztikai Kozpont / Saldinvest Kft.
Székesfehérvár, Hungary
Vital Medical Center - Reumatologia
Veszprém, Hungary
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.